Cargando…
A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy
CONTEXT: Diabetic neuropathy affects 10.5%–32.2% of diabetic population posing clinical burden onto society. AIMS: We aimed to study the efficacy, safety, and tolerability of methylcobalamin, methylcobalamin plus pregabalin, and methylcobalamin plus duloxetine in patients of painful diabetic neuropa...
Autores principales: | Sharma, Chetna, Kaur, Inderpal, Singh, Harpreet, Grover, Inderpal Singh, Singh, Jatinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641739/ https://www.ncbi.nlm.nih.gov/pubmed/34854403 http://dx.doi.org/10.4103/ijp.ijp_1159_20 |
Ejemplares similares
-
Efficacy and Tolerability of a Fixed Dose Combination of Methylcobalamin and Pregabalin in the Management of Painful Neuropathy
por: Prabhoo, Ram, et al.
Publicado: (2012) -
Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013) -
Methylcobalamin: A Potential Vitamin of Pain Killer
por: Zhang, Ming, et al.
Publicado: (2013) -
Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy
por: Maladkar, Manish, et al.
Publicado: (2009) -
Vitamin B(12) Supplementation and Methylcobalamin: Use or Misuse
por: Shubhakaran, Khichar Purnaram
Publicado: (2017)